+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Allergy Rhinitis Drugs Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • April 2021
  • Region: Global
  • TechNavio
  • ID: 5007857
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the allergy rhinitis drugs market and it is poised to grow by $2.96 bn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. Our report on allergy rhinitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergic rhinitis and increasing awareness about allergic rhinitis.

The allergy rhinitis drugs market analysis includes product segment and geographic landscape.

The allergy rhinitis drugs market is segmented as below:

By Product
  • Antihistamines
  • Intranasal corticosteroids
  • Immunotherapies
  • Others

By Geographic Landscape
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the high unmet medical needsas one of the prime reasons driving the allergy rhinitis drugs market growth during the next few years.

The report on allergy rhinitis drugs market covers the following areas:
  • Allergy rhinitis drugs market sizing
  • Allergy rhinitis drugs market forecast
  • Allergy rhinitis drugs market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy rhinitis drugs market vendors that include Adamis Pharmaceuticals Corp., ALK-Abello AS, Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Stallergenes Greer Ltd. Also, the allergy rhinitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Antihistamines - Market size and forecast 2020-2025
  • Intranasal corticosteroids - Market size and forecast 2020-2025
  • Immunotherapies - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor Landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Adamis Pharmaceuticals Corp.
  • ALK-Abello AS
  • Dr. Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Stallergenes Greer Ltd.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Antihistamines - Market size and forecast 2020-2025 ($ billion)
  • Antihistamines - Year-over-year growth 2020-2025 (%)
  • Intranasal corticosteroids - Market size and forecast 2020-2025 ($ billion)
  • Intranasal corticosteroids - Year-over-year growth 2020-2025 (%)
  • Immunotherapies - Market size and forecast 2020-2025 ($ billion)
  • Immunotherapies - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ billion)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Adamis Pharmaceuticals Corp. - Overview
  • Adamis Pharmaceuticals Corp. - Business segments
  • Adamis Pharmaceuticals Corp. - Key offerings
  • Adamis Pharmaceuticals Corp. - Key customers
  • Adamis Pharmaceuticals Corp. - Segment focus
  • ALK-Abello AS - Overview
  • ALK-Abello AS - Product and service
  • ALK-Abello AS - Key offerings
  • ALK-Abello AS - Key customers
  • ALK-Abello AS - Segment focus
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Key customers
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product and service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • Glenmark Pharmaceuticals Ltd. - Key customers
  • Glenmark Pharmaceuticals Ltd. - Segment focus
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Key customers
  • Merck and Co. Inc. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Stallergenes Greer Ltd. - Overview
  • Stallergenes Greer Ltd. - Product and service
  • Stallergenes Greer Ltd. - Key offerings
  • Stallergenes Greer Ltd. - Key customers
  • Stallergenes Greer Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global allergy rhinitis drugs market: Adamis Pharmaceuticals Corp., ALK-Abello AS, Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Stallergenes Greer Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the high unmet medical needs.'

According to the report, one of the major drivers for this market is the increasing prevalence of allergic rhinitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Adamis Pharmaceuticals Corp.
  • ALK-Abello AS
  • Dr. Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Stallergenes Greer Ltd.